Inventor · disambiguated record
Bart Henderson
Also filed as: HENDERSON BART · HENDERSON BART T
16 granted patents·4 pending applications·117 citations·filing 2007–2024
92Inventor score
Files withRHYTHM PHARMACEUTICALS INC12RADIUS HEALTH INC3DEY MICHAEL J2CHARITE UNIVERSITAETSMEDIZIN BERLIN1LYTTLE C RICHARD1
Top patents by PatentIndex Score
20 records- 0196US7803770B2Method of treating osteoporosis comprising administration of PTHrP analogRADIUS HEALTH INC·Filed 2008·Granted Sep 28, 2010·37 cites·14 claims
- 0293US8748382B2Method of drug delivery for bone anabolic proteinDEY MICHAEL J·Filed 2012·Granted Jun 10, 2014·19 cites·12 claims
- 0390US12285460B2Pharmaceutical compositionsRHYTHM PHARMACEUTICALS INC·Filed 2021·Granted Apr 29, 2025·1 cites·11 claims
- 0490USRE49444EMethod of treating osteoporosis comprising administration of PTHrP analogRADIUS HEALTH INC·Filed 2020·Granted Mar 7, 2023·2 cites·79 claims
- 0589US8148333B2Stable composition comprising a PTHrP analogueDEY MICHAEL J·Filed 2007·Granted Apr 3, 2012·22 cites·13 claims
- 0688US11129869B2Pharmaceutical compositionsRHYTHM PHARMACEUTICALS INC·Filed 2014·Granted Sep 28, 2021·5 cites·24 claims
- 0786US10954268B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·1 cites·18 claims
- 0886US10858399B2Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·2 cites·20 claims
- 0986US10196425B2Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2014·Granted Feb 5, 2019·7 cites·27 claims
- 1086US8933130B2Treatment of vasomotor symptoms with selective estrogen receptor modulatorsLYTTLE C RICHARD·Filed 2007·Granted Jan 13, 2015·17 cites·7 claims
- 1184US2025188124A1Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1284US2024190914A1Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1382US10167312B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·2 cites·14 claims
- 1480US2025195606A1Method of treating melanocortin-4 receptor pathway-associated disordersRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1576US11702448B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 1673US9845339B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM METABOLIC INC·Filed 2012·Granted Dec 19, 2017·2 cites·10 claims
- 1772US12263202B2Method of treating melanocortin-4 receptor pathway-associated disordersCHARITE—UNIVERSITAETSMEDIZIN BERLIN·Filed 2021·Granted Apr 1, 2025·0 cites·21 claims
- 1872US12077612B2Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2020·Granted Sep 3, 2024·0 cites·6 claims
- 1956US2011092425A1Method of drug delivery for bone anabolic proteinRADIUS HEALTH INC·Filed 2010·Application pending·0 cites
- 2054US10960046B2Method of treating melanocortin-4 receptor pathway-associated disordersRHYTHM PHARMACEUTICALS INC·Filed 2016·Granted Mar 30, 2021·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Bart Henderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →